U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 6718554

Hands free towel carrying system

A hands free towel carrying system for coupling a towel to a user to prevent loss, theft or contamination.

Newsletter  PatentStorm News

Make the Most of PatentStorm

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest patents by subscribing to an RSS feed.

Got questions? Ask a Patent Expert!

Registered users: Manage your profile, comments and alerts.

 

US Patent 6702997 - Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma

US Patent Issued on March 9, 2004
Estimated Patent Expiration Date: Icon_subject December 28, 2021Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
loading...


View Patent Images (PDF)
(Registered users only)

Abstract

The present invention relates to an albuterol inhalation solution, system, kit and method for relieving bronchospasm in children suffering from asthma. In one alternative embodiment, the solution of the present invention is a sterile, premixed, premeasured single unit dose of albuterol for asthmatic patients 2 to 12 years of age. The present solution may be free of anti-microbial preservatives, such as benzalkonium chloride. In another alternative embodiment, the solution of the present invention comprises about 0.63 mg or about 1.25 mg albuterol.

Other References

  • PDR's drug informationon Accuneb .RTM. (Dey), Sep. 2001. (obtained from on-line PDR).
  • Alderson S. H., Warren R. H.: "Pediatric Aerosol Therapy Guidelines" Indications, Techniques, and Dosages Clinical Pediatrics, vol. 23, No. 10, 1984, pp. 553-557
  • Global Burden of Disease and Injury Series Volume 1 The Global Burden of Disease--A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020--Christopher J.L. Murray, Harvard University, Boston, MA, USA; Alan D. Lopez, World Health Organization, Geneva, Switzerland (1996)
  • The Allergy Report American Academy of Allergy, Asthma & Immunology, Inc. Overview of Allegic Diseases--Diagnosis, Management, and Barriers to Care--vol. 1 Diseases of the Atopic Diathesis--vol. 2. Conditions That May Have an Allergic Component--vol. 3 (2000)
  • A Randomized Trial to Improve Self-Management Practices of Adults With Asthma Wiliam C. Bailey, MD; James M. Richard, Jr., PhD; C. Michael Brooks, EdD; Seng-jaw Soong: PhD; Richard A. Windsor, PhD, MPH: Bryn A. Manzella, MPH--Arch Inter Med--vol. 150, Aug. 1990 Adults With Asthma--Bailey et al
  • Patient error in use of bronchodilator metered aerosols British Medical Journal--Jan. 10, 1990
  • National Asthma Education and Prevention Practical Guide for the Diagnosis and Management of Asthma National Institutes of Health--Nationa Heart, Lung and Blood Institute NIH Publication No. 97-4053, Oct. 1997
  • Pediatric Management Problems Pediatric Nursing/May-Jun. 1994/vol. 20/No.3
  • Guidelines for the Diagnosis and Management of Asthma National Institutes of Health--National Heart, Lung and Blood Association--NIH Publication-No. 97-4051--Jul. 1997
  • National Institutes of Health National Heart, Lung, and Blood Insitute Data Fact Sheet--Asthma Statistics U.S. Department of Health and Human Services Jan. 1999
  • Morbility & Mortality: 2000 Chart Book on Cardiovascular, Lung and Blood Diseases--National Institutes of Health National, Heart, Lung, and Blood Institute May 2000
  • Xopenex™ (levalbuterol HCI) Inhalation Solution*, 0.63 mg, 1.25 mg (1992)
  • Ventolin.RTM. (albuterol, USP) Inhalation Aerosol Bronchodilator Aerosol For Oral Inhalation Only (2001)
  • JAMA Asthma Information Center--Oct. 26, 2001 Ventolin Syrup www.ama-assn-org/special/asthma/treatmnt/drug/ventolin.htm
  • Summary of Product Characteristics--Ventolin Nebules (1998-06) S: .backslash.Inetpub.backslash.wwwsites.backslash.corpdev.backslash.Product pdfs.backslash.uk_ventolin _nebules.doc
  • Product Information PROVENTIL.RTM.HFA http:fb.a-files.net/PackageInsert/schering/23800101.htm (1996)
  • Proventil.RTM. brand of albuterol sulfate, USP Inhalation Solution 0.083%*, Prescriber information. (1999)
  • Allergic Reactions in Children, Practical pharmacotherapy for Pediatric Asthma Douglas Barett, MD, Pediatric Annals, 29:12, Dec. 2000
  • Undiluted Albuterol Aerosols in the Pediatric Emergency Department David J. Gutglass, MD*; Louis Hampers, MD, MBA*; Doreen Teoh, MD*; Sai r. Nimmagadda, MD; and Steven E. King, MD, Pediatric, 105:5, May 2000 www.pediatrics.org./cgi/content/full/105/5e67
  • Efficacy of Albuterol in the Management of Bronchiolitis Anne M. Gadomski, MD: MPH; Richard Lichenstein, MD; Lisa Horton, MD, James King, MD; Virginia Keane, MD; and Thomas Permutt, PhD, Pediatrics, 93:6, Jun. 1994
  • A prospective, randomized study of continous versus intermittent nebulized albuterol for severe status asthmaticus in children Michele C. Papo, MD, MPD; John Frank; RRT' Ann E. Thompson, MD, FCCM, Critical Care Medicine, 21:10, Oct. 1993
  • Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mile and moderate acute pediatric asthma Francine M. ducharme, MD and G. Michael Davis, MD The Journal of Peidatrics--Oct. 1998
  • Continuous Nebulization: A Treatment Modality For Pediatric Asthma Patients. Sharon Ferrante, Eileen Painter Pediatric Nursing/July/Aug 1995/vol.21/No.4
  • The Clinical Efficacy of Nebulized Racemis Epinephrine and Albuterol in Acute Broncholitis Tiina Reijonen, MD; Matti Korppi, MD; Sirpa Pitkakangas, MD; Sirpoa Tenhola, MD; Kyllikki Remes, MD Arch Pediatr Adolesc Med/vol. 149, Jun. 1995
  • Low Dose B-Agonist Continuous Nebulization Therapy for Status Asthmaticus in Children Vicki L. Montogmery, MD, and Nemur S. Eid, MD Journal of Asthma, 31(3), 201-207 (1994)
  • Safety of Continuous Nebulized Albuterol for Bronchospasm in Infants and Children Robert W. Katz, MD; H. William Kelly, PharmD; Mark R. Crowley, MD; Roni Grad, MD; Bennie C. McWilliams, MD and Shirley J. Murphy, MD Demographic Characteristics of Patients Pediatrics vol. 92 No. 5 Nov. 1993
  • Nebulized Albuterol in Acute Childhood Asthma: Comparison of Two Doses Suzanne Schuh, MD, FRCP(C); Michael J. Reider, MD
  • Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children Joe Reiman, MD, Michele Galdes-Sebalt, MD, Farouk Kazim, MA, Gerard Canny MD and Henry Levision, MD Toronto, Ontario, Cancad--J. Allergy Clin. Immunol--Jan. 1988
  • Pediatric Pharmacology and Therapeutics--Clinical and Laboratory observations Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma Raphael Beck, MD, Colin Robertson, MD, Michele Galdes-Sebaldt, MD, and Henry Levison, MD The Journal of Pediatrics--vol. 107, No. 4, Oct. 1985
  • Bronchodilator Responsiveness in Normal Infants and Young Children Amy B. Goldstein, Robert G. Castile, Stephanie D. Davis, David A. Filbrun, Robert L. Flucke, Karen s. McCoy, and Robert S. Teppe Am J. Respir Crit Care Med vol. 164, pp. 447-454, 2001
  • Experience with a Metered-Dose Inhaler with a Spacer in the Pediatric Emergency Department Grey Benton, RRT, MA; Randolph C. Thomas, MD; Bruce G. Nickerson, MD; John C. McQuity, MD; Jerry Okikawa, RRT, MBA AJDC-vol. 143, Jun. 1989
  • Safety of Bronchodilator Therapy in Pediatic Asthma Patients--Jay E. Selcow, MD Department of Pediarics, Hartford Hospital, Harford, and University of Connecticut School of Medicime, Farmington, Connecticut Clinical Therapeutics/vol. 16, No. 4, 1994
  • Delivery of Aerosol Therapy in the Management of Pulmonary Disorder Drug Topics--Sep. 2000
  • Abstract: Preservatives in Nebulizer Solutions: Risk without Benefit Richard Beasley; MD, David Fishwick, MD, Jon F. Miles, MD and Leslie Hendeles, PharmD www.accp.com/pharmacotherpy/Abs 18_1/130.htm (1998)
  • Survey of the clinical use of pressurized aerosol inhalers S.W. Epstein, MD; C.P.R. Manning, ONCMLT; M.J. Ashley, MD, DPH, M. Sc; P.N. Corey, PhD CMA Journal/Apr. 7, 1979/vol. 120
  • Patient Assessment of Efficacy of Nebulizer Systems on their Respiratory Health Survey Results--Apr. 1995, Safian Communications

Inventors

Application

No. 10/034829 filed on 12/28/2001

US Classes:

424/45, Organic pressurized fluid128/200.14, LIQUID MEDICAMENT ATOMIZER OR SPRAYER424/450, Liposomes424/46, Powder or dust containing424/488, Polysaccharides (e.g., cellulose, etc.)424/78.12, Adsorbate or treating agent contains nitrogen514/169, Cyclopentanohydrophenanthrene ring system DOAI514/826ASTHMA

Field of Search

424/45, Organic pressurized fluid424/46, Powder or dust containing424/78.12, Adsorbate or treating agent contains nitrogen424/450Liposomes

Examiners

Primary: Hartley, Michael G.
Assistant: Haghighatian, M.

Attorney, Agent or Firm

US Patent References

3644353, 3879442, 4448776, Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
Issued on: 05/15/1984
Inventor: Bucher ,   et al.
4499108, Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
Issued on: 02/12/1985
Inventor: Sequeira ,   et al.
4751071, Composition comprising salbutamol
Issued on: 06/14/1988
Inventor: Magruder ,   et al.
4853381, Ethanolamine compounds
Issued on: 08/01/1989
Inventor: Finch ,   et al.
4908386, Ethanolamine derivatives
Issued on: 03/13/1990
Inventor: Finch, et al.
4939147, Substituted 3,4-dihydroxy phenylethylamino compounds
Issued on: 07/03/1990
Inventor: Dixon, et al.
5292499, Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
Issued on: 03/08/1994
Inventor: Evans, et al.
5340587, Liposome/bronchodilator method & System
Issued on: 08/23/1994
Inventor: Mihalko, et al.
5362755, Method for treating asthma using optically pure (R)-albuterol
Issued on: 11/08/1994
Inventor: Barberich, et al.
5393531, Process for the preparation of a pharmaceutical formulation containing at least two different active substances and use of such a formulation
Issued on: 02/28/1995
Inventor: Gerhard, et al.
5474759, Non-chlorofluorocarbon aerosol formulations
Issued on: 12/12/1995
Inventor: Fassberg, et al.
5508023, Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
Issued on: 04/16/1996
Inventor: Byron, et al.
5536444, Compressed-gas packages using polyoxyethylene glyceryl fatty-acid esters as suspension stabilizers and valve lubricants
Issued on: 07/16/1996
Inventor: Hettche, et al.
5538999, Medicament inhalation device and formulation
Issued on: 07/23/1996
Inventor: Clark, et al.
5603918, Aerosol composition of a salt of ipratropium and a salt of albuterol
Issued on: 02/18/1997
Inventor: McNamara
5674471, Aerosol formulations containing P134a and salbutamol
Issued on: 10/07/1997
Inventor: Akehurst, et al.
5676930, Stabilized medicinal aerosol solution formulations
Issued on: 10/14/1997
Inventor: Jager, et al.
5708036, Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
Issued on: 01/13/1998
Inventor: Pesterfield, Jr.
5763449, Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
Issued on: 06/09/1998
Inventor: Anaebonam, et al.
5844002, Method for inducing bronchodilation using optically pure R(-) albuterol
Issued on: 12/01/1998
Inventor: Barberich, et al.
5849265, Pharmaceutical aerosol formulation comprising a medicament, a propellant and a fluorinated surfactant
Issued on: 12/15/1998
Inventor: Li-Bovet, et al.
5902606, Solid and liquid solutions of sparingly water-soluble medicinal substances
Issued on: 05/11/1999
Inventor: Wunderlich, et al.
5919827, Method for treating asthma using optically pure R(-) salmeterol
Issued on: 07/06/1999
Inventor: Barberich, et al.
5955058, Stabilized medicinal aerosol solution formulations containing ipratropium bromide
Issued on: 09/21/1999
Inventor: Jager, et al.
5980882, Drug-resin complexes stabilized by chelating agents
Issued on: 11/09/1999
Inventor: Eichman
5981474, Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same
Issued on: 11/09/1999
Inventor: Manning, et al.
6007843, Sustained release delivery system
Issued on: 12/28/1999
Inventor: Drizen, et al.
6030604, Formulation for inhalation
Issued on: 02/29/2000
Inventor: Trofast
6030682, Container for aerosol formulation
Issued on: 02/29/2000
Inventor: Marecki
6057307, Use of mometasone furoate for treating airway passage and lung diseases
Issued on: 05/02/2000
Inventor: Sequeira, et al.
6083993, Method for treating bronchospasm using optically pure R(-) albuterol
Issued on: 07/04/2000
Inventor: Barberich, et al.
6123924, Pressurized aerosol inhalation compositions
Issued on: 09/26/2000
Inventor: Mistry, et al.
6136294, Amino acid stabilized medical aerosol formulation
Issued on: 10/24/2000
Inventor: Adjei, et al.
6153173, Propellant mixture for aerosol formulation
Issued on: 11/28/2000
Inventor: Sapsford, et al.
6153211, Biodegradable macromers for the controlled release of biologically active substances
Issued on: 11/28/2000
Inventor: Hubbell, et al.
6165500, Preparation for the application of agents in mini-droplets
Issued on: 12/26/2000
Inventor: Cevc
6221398, Process for the preparation of respirable particles
Issued on: 04/24/2001
Inventor: Jakupovic, et al.
6221887, Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists
Issued on: 04/24/2001
Inventor: Asghar, et al.
6228346, Propellant mixtures and aerosols for micronizing medicaments with compressed gas
Issued on: 05/08/2001
Inventor: Zhang, et al.
6235725, Methods and compositions for the prevention of tolerance to medications
Issued on: 05/22/2001
Inventor: Ahmed
6238647, Aerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethane
Issued on: 05/29/2001
Inventor: Akehurst ,   et al.
6251368, Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
Issued on: 06/26/2001
Inventor: Akehurst, et al.
6258341, Stable glassy state powder formulations
Issued on: 07/10/2001
Inventor: Foster, et al.
6261539, Medicinal aerosol formulation
Issued on: 07/17/2001
Inventor: Adjei, et al.
6284287, Particulate formulation for administration by inhalation
Issued on: 09/04/2001
Inventor: Sarlikiotis, et al.
6287540, Formulation for inhalation
Issued on: 09/11/2001
Inventor: Trofast
6294192, Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
Issued on: 09/25/2001
Inventor: Patel, et al.
6299861, Ipratropium bromide enantiomer with prolonged duration of effect
Issued on: 10/09/2001
Inventor: Banholzer, et al.
6451289Albuterol formulations
Issued on: 09/17/2002
Inventor: Wherry, III, et al.

International Class

A61K 31/137 (20060101)

Comments

No comments for this page
 
 
Forgot password?
Register here